Inventor · disambiguated record
Stanton Gerson
Also filed as: GERSON STANTON · GERSON STANTON L
22 granted patents·15 pending applications·1,042 citations·filing 1991–2025
96Inventor score
Top patents by PatentIndex Score
37 records- 0196US9801863B2Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesisUNIV CASE WESTERN RESERVE·Filed 2016·Granted Oct 31, 2017·10 cites·21 claims
- 0296US5591625ATransduced mesenchymal stem cellsUNIV CASE WESTERN RESERVE·Filed 1993·Granted Jan 7, 1997·433 cites·21 claims
- 0391US9789116B2Compositions and methods of modulating short-chain dehydrogenase activityUNIV CASE WESTERN RESERVE·Filed 2014·Granted Oct 17, 2017·16 cites·15 claims
- 0490US6010696AEnhancing hematopoietic progenitor cell engraftment using mesenchymal stem cellsOSIRIS THERAPEUTICS INC·Filed 1998·Granted Jan 4, 2000·235 cites·8 claims
- 0588US9790233B2Compositions and methods of modulating 15-PGDH activityUNIV CASE WESTERN RESERVE·Filed 2013·Granted Oct 17, 2017·11 cites·10 claims
- 0688US5733542AEnhancing bone marrow engraftment using MSCSFiled 1995·Granted Mar 31, 1998·219 cites·8 claims
- 0787US10301320B2Compositions and methods of modulating 15-PGDH activityUNIV CASE WESTERN RESERVE·Filed 2016·Granted May 28, 2019·7 cites·15 claims
- 0884US10945998B2Inhibitors of short-chain dehydrogenase activity for treating fibrosisUNIV CASE WESTERN RESERVE·Filed 2016·Granted Mar 16, 2021·5 cites·14 claims
- 0984US10869871B2Compositions and methods of modulating short-chain dehydrogenase activityUNIV CASE WESTERN RESERVE·Filed 2017·Granted Dec 22, 2020·5 cites·21 claims
- 1083US8324282B2Alkylating agent combinations in the treatment of cancerGERSON STANTON L·Filed 2003·Granted Dec 4, 2012·15 cites·12 claims
- 1183US6635677B2Methoxyamine combinations in the treatment of cancerUNIV CASE WESTERN RESERVE·Filed 2002·Granted Oct 21, 2003·11 cites·19 claims
- 1281US2024043443A1Compositions and methods of modulating 15-pgdh activityUNIV CASE WESTERN RESERVE·Filed 2023·Application pending·0 cites
- 1379US6465448B1Methoxyamine potentiation of temozolomide anti-cancer activityUNIV CASE WESTERN RESERVE·Filed 1999·Granted Oct 15, 2002·50 cites·21 claims
- 1479US2023285402A1Compositions and Methods of Modulating Short-Chain Dehydrogenase ActivityUNIV TEXAS·Filed 2023·Application pending·0 cites
- 1577US8716346B2Alkylating agent combinations in the treatment of cancerGERSON STANTON·Filed 2011·Granted May 6, 2014·2 cites·20 claims
- 1676US2023136730A1Compositions and methods of modulating short-chain dehydrogenase activityUNIV TEXAS·Filed 2022·Application pending·0 cites
- 1772US2020140453A1Compositions and methods of modulating 15-pgdh activityUNIV CASE WESTERN RESERVE·Filed 2019·Application pending·0 cites
- 1868US2021032265A1Compositions and methods of modulating 15-pgdh activityUNIV CASE WESTERN RESERVE·Filed 2020·Application pending·0 cites
- 1967US2025295640A1Inhibitors of short-chain dehydrogenase activity for treating fibrosisUNIV CASE WESTERN RESERVE·Filed 2025·Application pending·0 cites
- 2067US2021106587A1Compositions and methods of modulating short-chain dehydrogenase activityUNIV CASE WESTERN RESERVE·Filed 2020·Application pending·0 cites
- 2165US8367332B2Detection and quantification of abasic site formation in vivoUNIV CASE WESTERN RESERVE·Filed 2009·Granted Feb 5, 2013·0 cites·20 claims
- 2264US2021283113A1Inhibitors of short-chain dehydrogenase activity for treating fibrosisUNIV CASE WESTERN RESERVE·Filed 2020·Application pending·0 cites
- 2364US2024156764A1Inhibition of uracil dna glycosylase in the open conformationUNIV CASE WESTERN RESERVE·Filed 2023·Application pending·0 cites
- 2457US8791081B2MGMT inhibitor combination for the treatment of neoplastic disordersLIU LILI·Filed 2008·Granted Jul 29, 2014·0 cites·8 claims
- 2555US5300422AScreening method for controlling agranulocytosisUNIV CASE WESTERN RESERVE·Filed 1991·Granted Apr 5, 1994·19 cites·14 claims
- 2655US2009298077A1Assay for measurement of apurinic/apyrimidinic (ap) sites and for screening ap-site reactive compoundsXU YAN·Filed 2007·Application pending·0 cites
- 2753US10725042B2Methods of diagnosing and treating cancerUNIV CASE WESTERN RESERVE·Filed 2013·Granted Jul 28, 2020·0 cites·13 claims
- 2849US2023192717A1Compositions and methods of modulating short-chain dehydrogenase activityRODEO THERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 2948US9498489B2Antimetabolite agent combinations in the treatment of cancerLIU LILI·Filed 2010·Granted Nov 22, 2016·0 cites·18 claims
- 3046US2017071965A1Antimetabolite agent combinations in the treatment of cancerUNIV CASE WESTERN RESERVE·Filed 2016·Application pending·0 cites
- 3145US10722530B2Methods of diagnosing and treating cancerUNIV CASE WESTERN RESERVE·Filed 2017·Granted Jul 28, 2020·0 cites·26 claims
- 3242US2006178843A1Genetic markers in the CSF2RB gene associated with an adverse hematological response to drugsATHANASIOU MARIA·Filed 2006·Application pending·0 cites
- 3341US10718028B2Fluorescent probes for abasic site detectionCASE WESTERN RESERVE UIVERSITY·Filed 2016·Granted Jul 21, 2020·0 cites·12 claims
- 3441US2006183146A1Genetic markers in the HLA-C gene associated with an adverse hematological response to drugsATHANASIOU MARIA·Filed 2006·Application pending·0 cites
- 3541US2006177860A1Genetic markers in the HLA-DQBI gene associated with an adverse hematological response to drugsATHANASIOU MARIA·Filed 2006·Application pending·0 cites
- 3637US5965126Ause of mutant alkyltransferases for gene therapy to protect from toxicity of therapeutic alkylating agentsPENN STATE RES FOUND·Filed 1996·Granted Oct 12, 1999·4 cites·9 claims
- 3728US8318495B1Hematopoietic progenitor cell gene transductionGERSON STANTON L·Filed 1999·Granted Nov 27, 2012·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Stanton Gerson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →